eGenesis Company
Xenotransplant
Investors
Investor Type:
Late Stage Venture
Investors Number:
27
Employee Number:
11-50
Last Funding Date:
2021
Headquarters:
USA
Last Funding Type:
Series C
Total Funding:
$265.00
Founded Date:
2014
Industry:
Risk Mitigation
Estimated Revenue:
$10M to $50M